Navidea Biopharmaceuticals
(OTC) NAVBQ
Navidea Biopharmaceuticals Financials at a Glance
Market Cap
$100
Revenue (TTM)
$610.00
Net Income (TTM)
$1.18M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
2864.10 (High)
Dividend
$0.00
Beta (Volatility)
2864.10 (High)
Price
$0.00
Volume
25,210
Open
$0.00
Price
$0.00
Volume
25,210
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.05
Dividend
$0.00
Beta (Volatility)
2864.10 (High)
Price
$0.00
Volume
25,210
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.05
NAVBQ News
3 Stocks to Get on Your Watchlist
The 5 Most Misdiagnosed Diseases
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Navidea Biopharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
15
CEO
Michael S. Rosol, PhD
Website
www.navidea.comHeadquarters
Dublin, OH 43017-3552, US
NAVBQ Financials
Key Financial Metrics (TTM)
Gross Margin
-3%
Operating Margin
-214%
Net Income Margin
-231%
Return on Equity
0%
Return on Capital
3%
Return on Assets
-3%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$100.00
Shares Outstanding
100.08M
Volume
25.21K
Short Interest
0.00%
Avg. Volume
4.70K
Financials (TTM)
Gross Profit
$170.30K
Operating Income
$14.05M
EBITDA
$13.98M
Operating Cash Flow
$8.99M
Capital Expenditure
$390.35K
Free Cash Flow
$9.38M
Cash & ST Invst.
$2.00M
Total Debt
$2.44M
Navidea Biopharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$36.03K
+71.6%
Gross Margin
0.00%
N/A
Market Cap
$100.00
N/A
Market Cap/Employee
$9.09
N/A
Employees
11
N/A
Net Income
$2.26M
+60.5%
EBITDA
$2.10M
+62.3%
Quarterly Fundamentals
Net Cash
$2.61M
-6.3%
Accounts Receivable
$30.87K
-80.1%
Inventory
$460.75K
+137.7%
Long Term Debt
$269.00
-100.0%
Short Term Debt
$1.26M
+2202.9%
Return on Assets
-3.47%
N/A
Return on Invested Capital
2.52%
N/A
Free Cash Flow
$10.27M
-430.0%
Operating Cash Flow
$10.25M
-451.6%